Journal of the Arkansas Academy of Science
Volume 31

Article 26

1977

Immunization of Rats Against Mesocestoides corti (Cestoda) by
Subcutaneous Vaccination of Living Tetrathyridia and by Passive
Transfer with Serum
Jerry Y. Niederkorn
University of Arkansas

Follow this and additional works at: https://scholarworks.uark.edu/jaas
Part of the Immunity Commons, and the Zoology Commons

Recommended Citation
Niederkorn, Jerry Y. (1977) "Immunization of Rats Against Mesocestoides corti (Cestoda) by
Subcutaneous Vaccination of Living Tetrathyridia and by Passive Transfer with Serum," Journal of the
Arkansas Academy of Science: Vol. 31 , Article 26.
Available at: https://scholarworks.uark.edu/jaas/vol31/iss1/26

This article is available for use under the Creative Commons license: Attribution-NoDerivatives 4.0 International (CC
BY-ND 4.0). Users are able to read, download, copy, print, distribute, search, link to the full texts of these articles, or
use them for any other lawful purpose, without asking prior permission from the publisher or the author.
This Article is brought to you for free and open access by ScholarWorks@UARK. It has been accepted for inclusion
in Journal of the Arkansas Academy of Science by an authorized editor of ScholarWorks@UARK. For more
information, please contact scholar@uark.edu.

Journal of the Arkansas Academy of Science, Vol. 31 [1977], Art. 26

Immunization of Rats Against Mesocestoides corti
(Cestoda) by Subcutaneous Vaccination of Living
Tetrathyridia and by Passive Transfer With Serum
JERRY Y.NIEDERKORN

Department ot Zoology, University ot Arkansas at Fayetteville
Fayetteville,

Arkansas 72701

ABSTRACT

Laboratory rats were subcutaneously vaccinated with 100 live tetrathyridia ot Mesocestoides corti (Cestoda) and subsequently intraperitoneally challenged with 50 tetrathyridia.
Necropsy 30 days postintection revealed that vaccinated rats harbored 97.4% fewer worms
compared to control rats. In a second experiment, passive transfer of immunity was accomplished by immune serum from subcutaneously
vaccinated rats. Rats receiving
immune serum harbored 33.4% lighter worm burdens compared to normal serum recipients.
INTRODUCTION
Research on cestode immunology has focused on the relatively few
tapeworms with mammalian tissue-invading phases in their larval
development. The great majority of research has centered on Taenia
Linnaeus and Hymenolepis Weinland, possibly due to their economic
importance and the fact that both genera are relatively easy to maintain in the laboratory. Moreover, some species belonging to these
genera are pathogenic parasites of humans and domestic animals.
Therefore, a certain amount of economic impetus has accounted for
much of the immunological research regarding these tapeworms.
Protection against Mesocestoides corti infections has been accomplished by vaccination ofmice with excretory-secretory (ES) pro-

ducts collected from tetrathyridia incubated in vitroand by passive
transfer of serum from chronically infected mice (Kowalski and
Thorson 1972a, 1972b). Kazacos (1976) successfully immunized mice
against M. corti by subcutaneous inoculation of live tetrathyridia 21
days prior to intraperitoneal challenge infections.
As the relative rates of M.corti tetrathyridial proliferation are considerably lower in rats than mice (Specht and Voge 1965) it was of
interest to investigate the responses of rats to immunization procedures and to compare those results with the previously mentioned
studies performed with mice.
MATERIALS AND METHODS
Stock infections
Rats (Wooster-Ohio strain) were obtained from the Department of
Animal Science, University of Arkansas. Stock infections were maintained in young rats (6-8 weeks old). Tetrathyridia were washed in
three rinses of Kreb's ringer solution (pH 7.2) prior to intraperitoneal
(IP) injection with a sterile syringe fitted with a 21-gauge needle.
Worms were harvested from 30-day infections and used insubcutaneous (SC) vaccination procedures and in intraperitoneal (IP) challenge
infections.
Preparation of immune serum
Thirty rats (6-8 weeks old) were SC vaccinated with 100 tetrathyridia according to the procedures of Kazacos (1976). Serum was collected and pooled 21 days subsequent to SC vaccination.

Collection of serum
Blood was collected from control and SC vaccinated rats by
cardiac puncture using a sterile syringe fitted with a 21-gauge needle.
Blood was allowed to clot in sterile glass test tubes overnight at 2°C.
Sera from each treatment group were pooled, centrifuged (2200
rpm/10 min), and frozen until used. No preservatives were added to
any serum samples.
Subcutaneous vaccination and challenge infections
Fifteen rats (6-8 weeks old) were SC vaccinated with 100 tetrathyridia as previously described. Twenty-one days later 15 SC vaccinated rats and 15 control rats were IP infected with 50 tetrathyridia

using a sterile syringe fitted with a 21-gauge needle. Rats were
necropsied 30 days post-infection following the procedures of
Kowalski and Thorson (1972a). Worms were fixed in 10% formalin
prior to making direct worm counts of each rat's worm burden.

Passive transfer of serum and challenge infections
Thirty rats (6-8 weeks old) were IP infected with 50 tetrathyridia as
previously described. Within 2 hours each rat received an IP injection of either 2.0 ml of pooled immune serum or pooled normal
serum. Thirty days postinfection rats were necropsied and direct
worm counts were made as before.
Statistical analysis
Student's t-test was employed to determine the statistical significance between the worm burdens from treatment and control
groups. A probability value of 0.05 or less was considered significantlydifferent.
RESULTS
Subcutaneously

vaccinated

rats were highly resistant to IP chala 97.4% average reduction in worm
rats (Table 1). Moreover, 46.7% of the

lenge infections, demonstrating

burdens compared to control
SC vaccinated rats demonstrated a "sterile immunity" (i.e., no worms
were recovered). Livers were infected in only 26.7% of the SC vaccinated rats.
Passive transfer of immunity using pooled serum from SC vaccinated rats resulted in a 33.4% average reduction in worm burdens
compared to rats receiving normal serum (Table 1). Liver necropsies
revealed exceptionally light worm burdens in all 15 rats receiving
immune serum.
DISCUSSION

Subcutaneous vaccination of rats with live tetrathyridia produced a
high degree of protection to IP challenge infections. Kazacos (1976)
observed a 43.9% average reduction in worm burdens in mice SC
vaccinated and IP challenged with tetrathyridia of Mesocestoides
corti. As the rate of tetrathyridial proliferation is considerably slower
in rats than mice, it might be assumed that the "immuno-physiological" mechanisms of rats have a greater retarding effect on tetrathyridial proliferation than those mechanisms in mice. The results of the
present study suggest that prior SC vaccination augmented this process which resulted in significantly lower worm burdens and in some
cases, a "sterile immunity". It should be noted that in SC vaccinated
rats tetrathyridia were actually eradicated rather than just suppressed
from asexually reproducing. In contrast, Kazacos' (1976) study of SC
vaccinated mice revealed that tetrathyridia continued to asexually
proliferate, although at decreased rates.

As would be expected, passive transfer of pooled immune serum
was less effective inprotection than SC vaccination. Pooled immune
serum recipients demonstrated a 33.4% average decrease in worm
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burdens compared to rats receiving normal serum. In contract,
Kowalski and Thorson (1972a) demonstrated a 78% average reduction inM. corti worm burdens following passive transfer of immune
serum. Itshould be noted that they utilized serum from chronically
infected mice and the challenge infection period was 10 days while a
30-day infection period was used inthe present study.
The extremely low rate of tetrathyridial proliferation in rats necessitated a 30-day challenge infection period in the present study. A
greater reduction in worm burdens following serum treatment might
have been observed if rats were necropsied 10 days postinfection.
However, preliminary studies of rats harboring 10-day infections
indicated great disparities of worm burdens within treatment groups.
The fact that SC vaccination elicited a greater degree of protection
than immune serum suggests that other immunological factors might
augment humoral immune mechanisms against M.corti infections in
rats.

The complexities of cestode immunology remain to be completely
elucidated. The unique biological characteristics of the Mesocestoides corti tetrathyridium make it an ideal model for such investigations.

Table 1. Effects of subcutaneous
Mesocestoides cortiinrats.
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vaccination and passive transfer of serum on intraperitoneal challenge infections with tetrathyridia of
No. of tetrathyridia recovered
30 days pos t infe ct ion

No. of tetrathyridia in
IP challenge

No.

of
rats

Treatment

15

subcutaneous

Percent
reduction
Mean

(standard

error)

Total

compared

(range)

controls

50

2.8* (±0.88)

42 (0-20)

50

115.7 (±2.47)

1,646

(97-128)

50

74.7* (±3.08)

1,120

(49-90)

50

112.2 (±3.51)

1,683

(91-131)

to

97.4

vaccinat ion

15

untreated
cont rols

15

2.0 ml
immune

33.4

serum

15

2.0 ml
normal
serum

*

Significantly

80

different

from controls,

P<0.05
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